Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1 Trial to Assess Safety and Tolerability of a Single Dose of Streptococcus Pneumoniae Whole-Cell (wSp) Vaccine in Healthy Adults

NCT07059182 is registered in ClinicalTrials.gov with Serum Life Science Europe GmbH as lead sponsor.

NCT NCT07059182
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07059182 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1 Trial to Assess Safety and Tolerability of a Single Dose of Streptococcus Pneumoniae Whole-Cell (wSp) Vaccine in Healthy Adults
Lead sponsor
Serum Life Science Europe GmbH
Phase
Phase 1
Overall status
Completed
Start date
June 11, 2025
Completion date
August 29, 2025
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prevention of invasive pneumococcal disease, prevention of pneumococcal-induced acute otitis media